- Home
- VIR vs SILV Comparison
VIR vs SILV Comparison
Compare VIR & SILV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- SILV
- Stock Information
- Founded
- VIR 2016
- SILV 2015
- Country
- VIR United States
- SILV Canada
- Employees
- VIR N/A
- SILV N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- SILV Industrial Machinery/Components
- Sector
- VIR Health Care
- SILV Industrials
- Exchange
- VIR Nasdaq
- SILV Nasdaq
- Market Cap
- VIR 1.4B
- SILV 1.4B
- IPO Year
- VIR 2019
- SILV N/A
- Fundamental
- Price
- VIR $9.70
- SILV $11.06
- Analyst Decision
- VIR Buy
- SILV Buy
- Analyst Count
- VIR 6
- SILV 4
- Target Price
- VIR $34.83
- SILV $9.75
- AVG Volume (30 Days)
- VIR 3.8M
- SILV 1.7M
- Earning Date
- VIR 02-20-2025
- SILV 03-05-2025
- Dividend Yield
- VIR N/A
- SILV N/A
- EPS Growth
- VIR N/A
- SILV 0.18
- EPS
- VIR N/A
- SILV 0.58
- Revenue
- VIR $78,618,000.00
- SILV $278,078,000.00
- Revenue This Year
- VIR N/A
- SILV $3.21
- Revenue Next Year
- VIR N/A
- SILV $6.37
- P/E Ratio
- VIR N/A
- SILV $19.13
- Revenue Growth
- VIR N/A
- SILV 23.81
- 52 Week Low
- VIR $6.56
- SILV $4.83
- 52 Week High
- VIR $14.45
- SILV $11.91
- Technical
- Relative Strength Index (RSI)
- VIR 52.17
- SILV 61.61
- Support Level
- VIR $10.09
- SILV $9.54
- Resistance Level
- VIR $11.39
- SILV $11.07
- Average True Range (ATR)
- VIR 0.71
- SILV 0.48
- MACD
- VIR -0.11
- SILV 0.12
- Stochastic Oscillator
- VIR 16.57
- SILV 88.37
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About SILV SilverCrest Metals Inc.
SilverCrest Metals Inc involves in the exploration, development, and extraction of silver and other precious metals. The company's properties include Las Chispas, Cruz de Mayo, El Picacho and other projects.